Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gustaf Ahlén

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Methods to Evaluate Novel Hepatitis C Virus VaccinesGustaf Ahlén, Lars Frelin
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
Methods for monitoring gene gun-induced HBV- and HCV-specific immune responses in mouse modelsGustaf Ahlén, Matti Sällberg, Lars Frelin
Alimentary Pharmacology & Therapeutics|October 9, 2019
Editorial: HBV-the naked truth?Anna Pasetto, Gustaf Ahlén, Matti Sällberg
Vaccine|April 26, 2016
A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccinesSepideh Levander, Matti Sällberg, Gustaf Ahlén, et al.
Medical Microbiology and Immunology|December 24, 2014
Electroporation for therapeutic DNA vaccination in patientsMatti Sällberg, Lars Frelin, Gustaf Ahlén, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2014
Functional aspects of intrahepatic hepatitis B virus-specific T cells induced by therapeutic DNA vaccinationAnette Brass, Lars Frelin, David R Milich, et al.
Scientific Reports|May 5, 2016
Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responsesFredrik Holmström, Margaret Chen, Anangi Balasiddaiah, et al.
Molecular Therapy. Methods & Clinical Development|April 13, 2016
A targeted controlled force injection of genetic material in vivoGustaf Ahlén, Lars Frelin, Fredrik Holmström, et al.
Drug News & Perspectives|December 25, 2010
Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?Lars Frelin, Anette Brass, Gustaf Ahlén, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2014
Cleavage of the T cell protein tyrosine phosphatase by the hepatitis C virus nonstructural 3/4A protease induces a Th1 to Th2 shift reversible by ribavirin therapyErwin Daniel Brenndörfer, Anette Brass, Juliane Karthe, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Methods to Evaluate Novel Hepatitis C Virus VaccinesGustaf Ahlén, Lars Frelin
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
Methods for monitoring gene gun-induced HBV- and HCV-specific immune responses in mouse modelsGustaf Ahlén, Matti Sällberg, Lars Frelin
Alimentary Pharmacology & Therapeutics|October 9, 2019
Editorial: HBV-the naked truth?Anna Pasetto, Gustaf Ahlén, Matti Sällberg
Vaccine|April 26, 2016
A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccinesSepideh Levander, Matti Sällberg, Gustaf Ahlén, et al.
Medical Microbiology and Immunology|December 24, 2014
Electroporation for therapeutic DNA vaccination in patientsMatti Sällberg, Lars Frelin, Gustaf Ahlén, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2014
Functional aspects of intrahepatic hepatitis B virus-specific T cells induced by therapeutic DNA vaccinationAnette Brass, Lars Frelin, David R Milich, et al.
Scientific Reports|May 5, 2016
Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responsesFredrik Holmström, Margaret Chen, Anangi Balasiddaiah, et al.
Molecular Therapy. Methods & Clinical Development|April 13, 2016
A targeted controlled force injection of genetic material in vivoGustaf Ahlén, Lars Frelin, Fredrik Holmström, et al.
Drug News & Perspectives|December 25, 2010
Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?Lars Frelin, Anette Brass, Gustaf Ahlén, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2014
Cleavage of the T cell protein tyrosine phosphatase by the hepatitis C virus nonstructural 3/4A protease induces a Th1 to Th2 shift reversible by ribavirin therapyErwin Daniel Brenndörfer, Anette Brass, Juliane Karthe, et al.
Pageof 4